Please enable JavaScript to continue using this application.

Compare $TYRA vs $VOR | Chartloom

Compare

$TYRA vs $VOR

Tyra Biosciences Inc · Vor Biopharma Inc

TYRA

Tyra Biosciences Inc

VOR

Vor Biopharma Inc

Compare $TYRA vs $VOR

Comparing Tyra Biosciences Inc and Vor Biopharma Inc

TYRATyra Biosciences Inc

VORVor Biopharma Inc

TYRATyra Biosciences Inc

Market cap

$1.19B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-25.6%

52W performance

46.3%

FCF yield

-9.3%

VORVor Biopharma Inc

Market cap

$1.08B

P/E (TTM)

1.72x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

71.0%

52W performance

-40.4%

FCF yield

-13.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

TYRA

VOR

Detailed metrics comparison

TYRA

Tyra Biosciences Inc

VOR

Vor Biopharma Inc

Market Cap

TYRA$1.19B

VOR$1.08B

Enterprise Value

TYRA$1.11B

VOR$971M

Price

TYRA$19.94

VOR$19.90

P/E Ratio

TYRAN/A

VOR1.72x

P/S Ratio

TYRA0.00x

VOR0.00x

EV/Sales

TYRA0.00x

VOR0.00x

EV/EBITDA

TYRA0.00x

VOR0.00x

P/B Ratio

TYRA3.97x

VOR16.48x

P/FCF Ratio

TYRAN/A

VORN/A

EV/FCF

TYRA-10.12x

VOR-6.89x

PEG Ratio

TYRAN/A

VORN/A

Forward P/E (NTM)

TYRAN/A

VORN/A

Forward P/S (NTM)

TYRAN/A

VORN/A

Revenue (TTM)

TYRA$0

VOR$0

Revenue Growth (YoY)

TYRAN/A

VORN/A

Forward Rev Growth

TYRA680.8%

VOR488.1%

Gross Margin (TTM)

TYRA0.0%

VOR0.0%

Operating Margin (TTM)

TYRA0.0%

VOR0.0%

EBITDA Margin (TTM)

TYRA0.0%

VOR0.0%

Net Margin (TTM)

TYRA0.0%

VOR0.0%

FCF Margin (TTM)

TYRAN/A

VORN/A

Net Income (TTM)

TYRA$-149M

VOR$628M

FCF (TTM)

TYRA$-110M

VOR$-141M

EPS (TTM)

TYRA-$2.25

VOR$11.56

ROE (TTM)

TYRA-4639.0%

VOR-14213.0%

ROA (TTM)

TYRA-4307.0%

VOR154.2%

ROIC (TTM)

TYRA-4639.0%

VOR-14213.0%

Cash

TYRA$74M

VOR$108M

Debt

TYRA$0

VOR$0

Net Cash/Debt

TYRA$74M

VOR$108M

Current Ratio (TTM)

TYRA14.91x

VOR19.15x

Quick Ratio (TTM)

TYRA14.48x

VOR18.91x

Debt/Equity (TTM)

TYRA0.00x

VOR0.00x

Debt/Assets (TTM)

TYRA0.0%

VOR0.0%

Interest Coverage (TTM)

TYRAN/A

VORN/A

Net Debt/EBITDA (TTM)

TYRA0.00x

VOR0.00x

Beta

TYRA0.65

VOR1.70

52W Performance

TYRA46.3%

VOR-40.4%

YTD Performance

TYRA-25.6%

VOR71.0%

% from 52W High

TYRA-50.9%

VOR-40.6%

% from 52W Low

TYRA50.0%

VOR206.2%

Asset Turnover (TTM)

TYRA0.00x

VOR0.00x

FCF Yield (TTM)

TYRA-9.3%

VOR-13.1%

Earnings Yield (TTM)

TYRA-12.5%

VOR58.2%

Dividend Yield (TTM)

TYRAN/A

VORN/A

Rule of 40

TYRA0.0

VOR0.0

EV/GP/RG

TYRAN/A

VORN/A

Ticker research

View TYRA research View VOR research

Metric	TYRA Tyra Biosciences Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.19B	$1.08B
Enterprise Value	$1.11B	$971M
Price	$19.94	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.97x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	680.8%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-149M	$628M
FCF (TTM)	$-110M	$-141M
EPS (TTM)	-$2.25	$11.56
ROE (TTM)	-4639.0%	-14213.0%
ROA (TTM)	-4307.0%	154.2%
ROIC (TTM)	-4639.0%	-14213.0%
Financial Health
Cash	$74M	$108M
Debt	$0	$0
Net Cash/Debt	$74M	$108M
Current Ratio (TTM)	14.91x	19.15x
Quick Ratio (TTM)	14.48x	18.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.70
52W Performance	46.3%	-40.4%
YTD Performance	-25.6%	71.0%
% from 52W High	-50.9%	-40.6%
% from 52W Low	50.0%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-9.3%	-13.1%
Earnings Yield (TTM)	-12.5%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TYRA research	View VOR research

Valuation

P/E Ratio

VOR

1.72x

P/S Ratio

TYRA

0.00x

VOR

0.00x

EV/FCF

TYRA

-10.12x

VOR

-6.89x

Growth & revenue

Forward Revenue Growth

TYRA

680.8%

VOR

488.1%

Profitability & performance

Gross Margin

TYRA

0.0%

VOR

0.0%

ROE

TYRA

-4639.0%

VOR

-14213.0%

FCF Yield %

TYRA

-9.3%

VOR

-13.1%

52-Week Performance

TYRA

46.3%

VOR

-40.4%

Detailed metrics comparison

TYRA

Tyra Biosciences Inc

VOR

Vor Biopharma Inc

Market Cap

TYRA$1.19B

VOR$1.08B

Enterprise Value

TYRA$1.11B

VOR$971M

Price

TYRA$19.94

VOR$19.90

P/E Ratio

TYRAN/A

VOR1.72x

P/S Ratio

TYRA0.00x

VOR0.00x

EV/Sales

TYRA0.00x

VOR0.00x

EV/EBITDA

TYRA0.00x

VOR0.00x

P/B Ratio

TYRA3.97x

VOR16.48x

P/FCF Ratio

TYRAN/A

VORN/A

EV/FCF

TYRA-10.12x

VOR-6.89x

PEG Ratio

TYRAN/A

VORN/A

Forward P/E (NTM)

TYRAN/A

VORN/A

Forward P/S (NTM)

TYRAN/A

VORN/A

Revenue (TTM)

TYRA$0

VOR$0

Revenue Growth (YoY)

TYRAN/A

VORN/A

Forward Rev Growth

TYRA680.8%

VOR488.1%

Gross Margin (TTM)

TYRA0.0%

VOR0.0%

Operating Margin (TTM)

TYRA0.0%

VOR0.0%

EBITDA Margin (TTM)

TYRA0.0%

VOR0.0%

Net Margin (TTM)

TYRA0.0%

VOR0.0%

FCF Margin (TTM)

TYRAN/A

VORN/A

Net Income (TTM)

TYRA$-149M

VOR$628M

FCF (TTM)

TYRA$-110M

VOR$-141M

EPS (TTM)

TYRA-$2.25

VOR$11.56

ROE (TTM)

TYRA-4639.0%

VOR-14213.0%

ROA (TTM)

TYRA-4307.0%

VOR154.2%

ROIC (TTM)

TYRA-4639.0%

VOR-14213.0%

Cash

TYRA$74M

VOR$108M

Debt

TYRA$0

VOR$0

Net Cash/Debt

TYRA$74M

VOR$108M

Current Ratio (TTM)

TYRA14.91x

VOR19.15x

Quick Ratio (TTM)

TYRA14.48x

VOR18.91x

Debt/Equity (TTM)

TYRA0.00x

VOR0.00x

Debt/Assets (TTM)

TYRA0.0%

VOR0.0%

Interest Coverage (TTM)

TYRAN/A

VORN/A

Net Debt/EBITDA (TTM)

TYRA0.00x

VOR0.00x

Beta

TYRA0.65

VOR1.70

52W Performance

TYRA46.3%

VOR-40.4%

YTD Performance

TYRA-25.6%

VOR71.0%

% from 52W High

TYRA-50.9%

VOR-40.6%

% from 52W Low

TYRA50.0%

VOR206.2%

Asset Turnover (TTM)

TYRA0.00x

VOR0.00x

FCF Yield (TTM)

TYRA-9.3%

VOR-13.1%

Earnings Yield (TTM)

TYRA-12.5%

VOR58.2%

Dividend Yield (TTM)

TYRAN/A

VORN/A

Rule of 40

TYRA0.0

VOR0.0

EV/GP/RG

TYRAN/A

VORN/A

Ticker research

View TYRA research View VOR research

Metric	TYRA Tyra Biosciences Inc	VOR Vor Biopharma Inc
Market & Valuation
Market Cap	$1.19B	$1.08B
Enterprise Value	$1.11B	$971M
Price	$19.94	$19.90
P/E Ratio	N/A	1.72x
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	3.97x	16.48x
P/FCF Ratio	N/A	N/A
EV/FCF	-10.12x	-6.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	680.8%	488.1%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-149M	$628M
FCF (TTM)	$-110M	$-141M
EPS (TTM)	-$2.25	$11.56
ROE (TTM)	-4639.0%	-14213.0%
ROA (TTM)	-4307.0%	154.2%
ROIC (TTM)	-4639.0%	-14213.0%
Financial Health
Cash	$74M	$108M
Debt	$0	$0
Net Cash/Debt	$74M	$108M
Current Ratio (TTM)	14.91x	19.15x
Quick Ratio (TTM)	14.48x	18.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.65	1.70
52W Performance	46.3%	-40.4%
YTD Performance	-25.6%	71.0%
% from 52W High	-50.9%	-40.6%
% from 52W Low	50.0%	206.2%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-9.3%	-13.1%
Earnings Yield (TTM)	-12.5%	58.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View TYRA research	View VOR research